Farmhispania Group is a Spanish leading CDMO company at the forefront of research, development and commercialization of small molecule APIs, HPAPIs and relevant cGMP Adv. IMs for the brand pharmaceutical industry. With 2 multi-purpose cGMP manufacturing plants – located in the industrial outskirts of Montmelo’ (Barcelona, Spain) and Zaragoza (Zaragoza, Spain) – FHG is housing over 120+ reactors with a collectively 436 m3 of reactor volume capacity to meet a wide reaction technology portfolio (total- & semi-synthesis & fermentation capabilities) to support DS CMC & commercial programs.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Substance Manufacturing (API);Research & Development;Clinical Trials materials and logistics;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

6-10

High Potent Products capabilities:

OEB 3;OEB 4-5;OEB >5

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);GMP;PMDA (Japan);ANVISA (Brazil)